Orthofix Schedules Fourth Quarter and Fiscal 2019 Earnings Release and Conference Call for February 24, 2020

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the fourth quarter and fiscal 2019 after market close on Monday, February 24, 2020. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 4:30 p.m. ET the same day.

Interested parties may access the conference call by dialing [phone] in the U.S. and [phone] outside the U.S., and referencing the conference ID 8228975. A replay of the call will be available for two weeks by dialing [phone] in the U.S. and [phone] outside the U.S., and entering the conference ID 8228975. A webcast of the conference call may be accessed by going to the Company's website www.orthofix.com by clicking on the Investors link and then the Events and Presentations page.

About Orthofix:

Orthofix Medical Inc. is a global medical device company focused on musculoskeletal products and therapies. The Company’s mission is to improve patients' lives by providing superior reconstruction and regenerative musculoskeletal solutions to physicians worldwide. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedic extremities products are distributed in over 70 countries via the Company's sales representatives and distributors. For more information, please visit www.orthofix.com.